RankAlpha logo
Back to Rankings

CLDX

Celldex TherapeuticsC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
CLDX vs peer average
53/100
CLDX vs. peer average (C vs. C)
Grade spread
B 3 · C 3 · D 5
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

IMCR is the first available peer comparator.

Immunocore is a reasonable direct biotech milestone peer because valuation is still heavily driven by pipeline readouts and franchise durability rather than mature earnings power.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerIMCRImmunocore American
CLDX
Celldex Therapeutics
IMCR
Immunocore American
Grade
C
D
Momentum
76
57
Value
41
41
Sentiment
41
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs IMCR

CLDX / IMCR
Grade Position
In line
CLDX vs. peer average (C vs. C)
53/100
Momentum
76
CLDX
Value
41
CLDX
Sentiment
41
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CLDX
1
IMCR
IMCR
D
40/100
+1
2
MNKD
MNKD
B
80/100
-1
3
ANIP
ANIP
C
60/100
Even
4
SUPN
Supernus Pharmaceuticals Inc Common
B
80/100
-1
5
RARE
Ultragenyx Pharmaceutical Inc Common
C
60/100
Even
IMCR is the first peer returned for this comparison set.